Ricupati Agostino reported acquisition or exercise transactions in this Form 4 filing.
Rocket Lab Corp executive Agostino Ricupati, VP Corp Controller & CAO, received a grant of 27,532 restricted stock units (RSUs) of common stock as equity compensation. The RSUs were granted at $0.00 per share, so he did not buy shares on the open market.
All 27,532 shares are reported as owned directly after the grant. The RSUs vest over time under the Rocket Lab Corporation 2021 Stock Option and Incentive Plan: 1/16 vests on August 22, 2026, and 1/16 vests on each March 1, May 22, August 22 and November 22 thereafter, as long as he remains in continuous service.
Rocket Lab Corp executive Ricupati Agostino, the company’s VP Corporate Controller and Chief Accounting Officer, filed an initial Form 3 insider report. The filing lists him as an officer and shows no reported purchases, sales, option exercises, gifts, or other insider transactions in this statement.
Rocket Lab Corporation appointed Agostino Ricupati as Vice President, Corporate Controller and Chief Accounting Officer, making him the company’s principal accounting officer. He brings more than two decades of senior finance and accounting experience at large public companies, including Cooper Companies and Intel.
Ricupati’s compensation includes a $350,000 annual base salary, a discretionary target bonus equal to 40% of base salary for 2026, a $50,000 sign-on bonus, a temporary housing stipend up to $5,000 per month for seven months, and a four-year vesting RSU award valued at $3,000,000. Adam C. Spice will cease serving as principal accounting officer but will remain Chief Financial Officer and principal financial officer.
Rocket Lab Corp Chief Financial Officer Adam C. Spice reported non-market transfers of common stock. On May 29 and June 1, 2026, he made bona fide gifts totaling 188,172 shares, including transfers to trusts where he serves as trustee, at a reported price of $0.00 per share.
After these gifts, Spice holds 920,325 shares of common stock directly and 250,000 shares indirectly through a trust, indicating the reported transactions represent a portion of his overall position rather than a sale into the market.
Rocket Lab Corp director Frank Edward H. reported two bona fide gift transfers of the company’s common stock on May 29, 2026. He gifted 91,373 shares to a family trust where he serves as trustee, and a separate 91,373-share gift reduced his direct holdings to 53,613 shares. These are non-market, zero-price transfers for estate or family planning rather than open-market sales or purchases.
Rocket Lab Corp director-related entity reports stock sales. On May 28, 2026, Abalone Cove LLLP, an entity associated with director Alexander R. Slusky, sold 20,000 Rocket Lab common shares in an open-market sale at $150.0000 per share and 40,000 shares at $149.1023 per share. The weighted-average sale prices for these trades ranged from $149.0000 to $149.4100. After these transactions, Abalone Cove LLLP held 374,675 Rocket Lab common shares indirectly, while Slusky also reported 61,331 shares held directly.
Rocket Lab Corp Chief Operations Officer Frank Klein reported open-market sales of 36,860 shares of Common Stock on May 28, 2026. The shares were sold in multiple transactions at weighted-average prices ranging from $142.5900 to $150.4500, executed automatically under a Rule 10b5-1 trading plan adopted on September 19, 2025. Following these sales, Klein directly holds 1,006,987 shares of Rocket Lab common stock.
Rocket Lab Corp executive Marvin Bradford Clevenger, President of Rocket Lab USA, Inc, sold 3,500 shares of Common Stock in an open-market transaction on May 28, 2026. The weighted-average sale price was $146.6731 per share, across trades ranging from $146.60 to $146.78. After this sale, Clevenger directly holds 473,975 Rocket Lab shares.
Rocket Lab Corp reported that SVP & General Counsel Arjun Kampani sold a total of 23,804 shares of common stock in open-market transactions on May 28, 2026. These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 19, 2025, at weighted-average prices ranging from $142.76 to $150.42. No derivative securities transactions were reported in this filing.
Alexander R. Slusky filed a Form 144 reporting a proposed sale of 100,000 shares of Common Stock, dated 05/12/2026. The filing shows a reported value of $11,807,636.48 and lists 578,750,990 shares outstanding with an 05/28/2026 reference.
This notice is a regulatory disclosure of an intended resale under Rule 144; it is a routine broker‑facilitated filing and does not by itself confirm completion of a sale or the method of sale.